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Introduction
Epilepsy is among the most common neurological disorders requiring chronic therapeutic management. Thirty percent of all patients do not respond to available anti-epileptic drugs (AEDs) (Potschka and Brodie, 2012 ) with a particular high rate of drug resistance in patients with acquired epilepsies. Limitations in epilepsy treatment spur a growing interest in the development of preventive approaches, which can be applied in patients who experienced an epileptogenic brain insult (Kobow et al., 2012) . The design and validation of respective approaches faces several challenges. The complexity of the molecular and cellular alterations characterizing epileptogenesis following an initial brain insult renders it difficult to pick the most promising targets for anti-epileptogenic concepts in a straightforward manner. The uncertainty in the timing of epileptogenesis requires elaborate and time-consuming preclinical and clinical research (White, 2012 , Schmidt, 2012 . Post-insult epilepsy can develop with a latency period of months, years, or even decades (Schmidt, 2012, Trinka and Brigo, 2014) .
Biomarkers that allow for early conclusions about the success of an intervention and limit the necessary duration of a clinical trial are urgently needed. Brain insults only pose patient subgroups at risk for epilepsy development with the individual outcome depending on various factors including genetic and physiological factors as well as, the disease history.
Stratification of patients with a comparable brain insult by an actual risk of epileptogenesis is highly desirable. For these purposes the availability of valid epileptogenesis biomarkers, which for instance render a basis for respective molecular imaging approaches, is essential.
Moreover, an in-depth understanding of the sequence of pathophysiological events is a prerequisite for the rationale selection of target candidates and the respective time window for intervention.
Animal models of epileptogenesis can provide information about the regulation patterns of functional groups of proteins. Bioinformatic approaches to analyze genomic, transcriptomic
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4 and proteomic data can integrate the complex data from such omics studies with the vast amount of information collected and curated in biological databases. Findings obtained can guide the selection of novel target and biomarker candidates.
Knowledge-based proteomics analysis can provide comprehensive information about diseaseassociated alterations in molecular patterns at the functionally relevant level and might guide the identification of key proteins in the pathogenesis of epilepsy. Therefore, we collected individual hippocampal and parahippocampal cortex samples in a rat model at three different time points during epileptogenesis and analysed the proteome alterations using an LC/MS-MS approach. Here, we completed a broader analysis of the data set previously subjected to an analysis focused on proteins specifically linked with inflammation and immune response (Walker et al., 2016) . We applied a Weighted Gene Co-expression Network Analysis (WGCNA) approach (Langfelder and Horvath, 2008) to unveil a network of epileptogenesisassociated protein modules and to identify intramodular hub proteins. WGCNA has been successfully applied to discover hub gene association in many conditions including atrial fibrillation (Tan et al., 2013 ), Alzheimer's disease (Miller et al., 2010 ), Huntington's disease (Shirasaki et al., 2012) , autism spectrum disorder (Huang et al., 2016) , and schizophrenia (Ren et al., 2015 , de Jong et al., 2012 . The findings can guide future selection of promising target candidates and their rational combination in multi-targeting approaches.
To identify proteins that distinguish between groups and might serve as biomarker candidates,
we have subjected the protein data sets collected during the early post-insult phase, the latency phase, and the chronic epilepsy phase to principal component analysis. The results suggest several novel proteins that are prominently regulated during epileptogenesis, and that might serve as potential target and biomarker candidates. Processed data are available as supplementary file, Cytoscape network files and R scripts are available as hosted at http://doi.org/10.5281/zenodo.438918.
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Materials and Methods
Animals
The animal experiment of this study has been carried out in accordance with the German Animal Welfare act and the EU directive 2010/63/EU as approved by the responsible government (reference number 55.2-1-54-2532-94-11). Female Sprague Dawley rats (n= 59;
200-224 g) were used in the experiment and were housed under controlled standard environmental conditions (20-24°C, 45-65 % humidity, light cycle from 7:00 a.m.-7:00 p.m.).
Please note that female rats were used based on our characterization of the model (Brandt et al., 2003) , which revealed a high mortality rate in male rats.
The rats were purchased from Harlan Laboratories (Udine, Italy) and were allowed to habituate to the new environmental conditions for at least one week. During the experiment every attempt was made to minimize the number of animals used in the study and to avoid any pain or discomfort.
Post-status epilepticus model
Stereotactical implantation of the combined recording and stimulation electrode into the right anterior basolateral amygdala was performed as previously described by Walker et al. (2016) .
With a time interval of at least six weeks post-surgery a status epilepticus (SE) was induced as described by Ongerth et al. (2014) . Two days, ten days and eight weeks post SE, the rats were sacrificed and brain tissue of the hippocampus (HC) and parahippocampal cortex (PHC) was used for mass spectrometry. Animals from the eight weeks group underwent a continuous video-and EEG-monitoring (24 h per day / 7 days a week over 19 days) using a combined EEG-and video-detection system as previously described by (Pekcec et al., 2008) . Only animals with at least one spontaneous generalized seizure were used for further analysis.
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Mass spectrometry, label-free quantification and protein identification Control (n = 5) and SE (n = 5) animals were euthanized with pentobarbital (500 mg/kg i.p.; Narcoren ® , Sigma-Aldrich GmbH, Munich, Germany). Tissue preparation and LC-MS/MS analysis were performed as described previously (Walker et al., 2016) . For label-free quantification and protein identification the acquired MS spectra were loaded into the Progenesis LC-MS software (Version 2.5, Nonlinear Dynamics) and label-free quantification was analysed as described by Hauck et al. (Hauck et al., 2010 ) and Walker et al. (2016 . Briefly, only unique peptides of an identified protein were used for quantification. To measure the total cumulative normalized abundance all peptides assigned to the respective protein were summarized. Only proteins quantified with at least two peptides were included for further analysis.
Pre-processing of data
Following LC-MS/MS, the corresponding gene symbols for all quantified proteins were taken from the Ensembl database (http://www.ensembl.org/Rattus_norvegicus/; version 69; 32971 sequences). In case a gene symbol had not been established in the rat genome annotation, the human orthologue was used. Proteins with missing values were excluded from further analysis. Expression values of each time point were arcsine-transformed, median centered and analysed by principal component analysis (PCA) implemented in R software packages "FactoMineR" (Lê et al., 2008) and "factoextra" (Kassambara, 2015) . To explain variation between protein profiles of SE and control groups, the top 10 contributing proteins at the first PCA dimension were further analysed.
Differentially expressed proteins were defined as proteins with fold change ≥ 1.5 (upregulated in SE samples) or fold change ≤ 0.67 (down-regulated in SE samples) and p-values < 0.05, estimated by empirical Bayes method in "limma" R package (Smyth, 2004) .
Protein co-expression network construction and module detection
To study the correlation of protein expression profiles between different time points, further analysis was comprised of proteins identified at all three time points. Some identified proteins mapped to the same gene symbol; we selected the ones that had the highest number of unique peptides, which were used for quantification. Protein co-expression networks were constructed with the R package WGCNA (Weighted Gene Co-expression Network Analysis) (Langfelder and Horvath, 2008) . We calculated Spearman correlation coefficient between normalized protein expression profiles and converted the correlation matrix into a weighted adjacency matrix with a soft threshold β = 6. Topological analysis by density, centralization, heterogeneity, mean clustering coefficient and mean scaled connectivity were retrieved by the function fundamentalNetworkConcepts of WGCNA and modules were identified by topological overlap dissimilarity measure. Topological overlap indicates the relative interconnectedness between two molecules, thus identification of modules from topological dissimilarity results in membership of proteins that have a similar expression pattern.
Dynamic tree cut of the network dendrogram was performed with parameters minClusterSize = 20 and deepSplit = 2.
Hub proteins and module significance
The proteins with highest connectivity within the module were defined as intramodular hubs.
Since the biological plausibility and clinical utility of hubs varies, functional enrichment of the module can further help to prioritize the hub proteins for validation. Functional enrichment was determined by Core Analysis in Ingenuity Pathways Analysis (IPA; (Racine et al., 2011) ). Disease association of the hub proteins was performed in DisGeNET (Pinero et al., 2015) and IPA. DisGeNET scores represent the level of evidence for gene-disease
association, based on the number and type of sources (level of curation, model organisms) and the number of publications supporting the association.
The network was exported for visualization in Cytoscape (Shannon et al., 2003) 
Immunohistochemistry
Immunohistochemistry was performed for three selected proteins to confirm the result of mass spectrometry analysis. For this purpose, animals were euthanized with an intraperitoneal injection of pentobarbital (500 mg/kg; Narcoren ® , Sigma-Aldrich GmbH, Munich, Germany).
Next, animals were decapitated, the brains were removed and stored in 4% paraformaldehyde in 0.1 M phosphate-buffered saline (pH 7.4) at 4 °C for three days. Serial blocks were embedded in paraffin by using an embedding workstation (Histomaster 2050/Di, Bavimed, Birkenau, Germany). Coronal sections (2 µm) were cut on a microtome (1165/Rotocut, Reichert-Jung, Nußloch, Germany) from these blocks and representative regions were selected for immunohistochemistry. For the PHC stainings (annexin A3, eukaryotic
translation initiation factor 3 subunit C) we used sections close to bregma = -4.80, while for HC staining (clusterin) we used bregma = -5.40 according to the rat stereotaxic atlas (Paxinos and Watson, 2007) , for all tissues we used the whole mount staining technique. Briefly, sections were initially deparaffinized with ethanol scale, processed for heat-induced epitope retrieval (HIER) with sodium citrate buffer (pH 6.0) in microwave oven at 720 W for 20 min.
Samples were then washed in 0.01 M PBS at room temperature and endogenous peroxidase RRID:AB_2336818) and stained using the avidin-biotin complex indirect technique (Gualtieri et al., 2012) with diaminobenzidine tablets (Sigma Aldrich, D4293 SIGMAFAST 3,3′-Diaminobenzidine tablets) as chromogen. Brain samples were then rinsed in water, dried and coverslipped with mounting medium (Millipore -107960 Entellan) for image analysis.
Image analysis
For each animal, images for the HC or PHC were captured at 10x magnification by an Olympus BH-2 microscope connected to a video camera (Zeiss AxioCam MRc, Germany) and post processed for analysis with ImageJ software (NIH, USA) and Adobe Photoshop CS6
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(Adobe Systems, USA). The person performing the quantification was unaware of the group allocation of the samples.
Images were processed for area measurement and were initially converted in 8bit type; the region of interest (ROI) for each staining was outlined. For annexin A3 we analyzed the piriform cortex, for clusterin the dorsal and the ventral HC, for eukaryotic translation initiation factor 3 subunit C the amygdalopiriform transition. The threshold function was then applied to the ROI and the triangle filter (Zack et al., 1977) was chosen since this implementation uses robust (default is 1% and 99%) estimation of image histogram ends. For every image, thresholded and total ROI areas were obtained and the amount of thresholded was normalized on the investigated area as follows:
Values obtained for each experimental group were compared between SE animals and control animals for each protein marker.
Statistical analysis
Immunhistochemistry data were analyzed using Prism 5.0 (Graphpad Software, USA).
Statistical analysis was performed with t-test. All values are expressed as mean ± SEM. For all analyses p < 0.05 was considered statistically significant.
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Results
Data preprocessing
A total of 2,653 proteins were detected in at least one time point by LTQ OrbitrapXL, 2,241 in the HC samples and 2,394 in the PHC.
In 
HC and PHC networks and modules
Weighted co-expression networks were constructed from all proteins identified at three time points in the HC and PHC. The constructed networks had a similar topology in terms of density, heterogeneity, and clustering coefficient (Supplementary Table 1 In the PHC module 5 is characterized by enrichment of pathways linked with the regulation of cell death and apoptosis (EIF2 signaling, regulation of eIF4 and p70S6K signaling, phagosome maturation, mTOR signaling). PHC module 8 comprises pathways involved in plasticity and leukocyte transendothelial migration (signaling by Rho family GTPases, RhoA signaling, actin cytoskeleton signaling, leukocyte extravasation signaling).
Highly connected nodes of the network, often called hubs, serve as the information flow centers in the small-world, free-scale networks (Albert et al., 2000) . Multiple molecular and brain networks indicated that hub targeting leads to lethal effect on the functional level (Jeong et al., 2001 , Stam et al., 2007 . Thus, hubs can be considered as regulatory elements of the modules. We highlighted the top 15 connected proteins within SE-associated modules and indicated their relative degree by the font size (Figure 4 ). The lists of top 5 connected proteins per module were further checked for significantly regulated hub proteins. In the HC the majority of significantly regulated hub proteins proved to be down-regulated (Table 1) . Only
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A C C E P T E D M A N U S C R I P T selected hippocampal hub proteins exhibited an upregulation. These included acyl-CoA dehydrogenase, long chain (HC module 4) induced during the latency phase, i.e. ten days following SE, as well as clusterin (HC module 7) induced at all time points during epileptogenesis and following epilepsy manifestation (Table 1) . A higher number of hub proteins showed an overexpression in the PHC (Table 2) the dataset generated by Niesen et al. (2013) . They reported a regulation of metabolismassociated pathways. In our study we identified module 8 in the HC data sets, which was functionally dominated by pathways involved in cellular metabolism.
In general, it needs to be taken into account that comparison of different data sets faces major limitations related to different study approaches including time of sampling and different techniques a direct comparison between studies is biased. When comparing data for different brain regions across studies, these are of course often contrasting. For instance, in a transcriptomic analysis a hippocampal down-regulation of H2A histone family, member Y has been described which persisted during epileptogenesis (Hansen et al., 2014) We observed an induction for this protein at all analysed time points in the PHC.
In-silico result validation
To validate the identified hubs and functional modules, we additionally analysed the proteomic data set provided by Bitsika et al. (2016) . The main differences between our and ACCEPTED MANUSCRIPT
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Bitsika's data set were the model organism (rat vs. mouse), SE induction (electrical vs. kainic acid (KA)) and the measured time points (two days, ten days and eight weeks vs. one, three and 30 days). Despite the great differences between data sets, the same supporting findings will indicate that the results are robust across organisms and SE models. In the following we refer to our present data sets as HC and PHC.
Briefly, the Bitsika data set underwent the same preprocessing and network construction 
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Next, we compared if some hub proteins from our data set also appeared as hubs in Bitsika modules. Several hub proteins including bassoon (presynaptic cytomatrix protein) (HC 7, Bitsika 10), clusterin (HC 7, Bitsika 4), heat shock protein 4-like (PHC 1, Bitsika 7), myosin XVIIIa (HC 5, Bitsika 9) and 14-3-3 protein theta (PHC 12, Bitsika 2) exhibited an overlap between modules from the two studies.
Principal component analysis (PCA)
The analysis of PCA data was focused on dimension 1 (principal component 1), which by definition exhibits the largest variation between groups under comparison. It is interesting to note that there is an obvious clustering of the subgroup's HC data along dimension 1 two and ten days but not eight weeks post SE. In contrast, clustering of PHC data is evident at all three time points (Figure 6 ).
Among top 10 proteins that contribute to variability of principal component 1 (PC1), there are some that exhibit a high fold change (Table 3 and 4). In accordance with our aim to identify interesting biomarker candidates of epileptogenesis and early epilepsy onset we have searched these lists for proteins with an upregulation of at least 1.5 fold. In the early post insult phase (two days post SE) three proteins contributing to PC1 variability exhibited a strong induction.
These included CD151 molecule, mannose-P-dochilol utilization defect 1 protein and clusterin. During the latency phase (ten days post SE) ectonucleoside triphosphate diphosphohydrolase 1 and plexin B2 proved to be up-regulated among the PC1 top 10
proteins. In the PHC only one PC1 top 10 protein exhibited a significant induction ten days post SE. In the chronic phase following epilepsy manifestation, four proteins of the PC1 top 10 list showed an overexpression: ATP synthase, H + transporting mitochondrial Fo complex, subunit F2; glutathione S-transferase alpha; proteasome subunit beta type 3; purine nucleoside phosphorylase.
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Immunohistochemistry
For validation purposes we selected three proteins for immunohistochemistry based on the results of the network analysis and PCA.
Ten days following SE an increased expression of eukaryotic translation initiation factor 3 subunit C was evident in the PHC of animals with SE. The difference was most pronounced in the amygdalopiriform transition. Animals with SE exhibited small immunopositive cells in this region that were not present in control animals ( Supplementary Figure 8a and 
A C C E P T E D M A N U S C R I P T
Discussion
To our knowledge, this study provides the first comprehensive WGCNA-based systems biology analysis, which provides an in-depth characterization of the epileptogenesisassociated proteomic network alterations. A broad functional annotation analysis revealed a pronounced regulation of several functional groups of proteins. Both, in the HC and PHC the most prominent molecular alterations in the respective groups were evident during the latency phase, i.e. ten days following the epileptogenic brain insult. This time course seems to reflect the alterations at the cellular and network level, which of course require a high intensity of molecular processes. Thus, it is not surprising that the groups exhibiting the most pronounced regulation including several protein groups, which play a key role in synaptic and cellular plasticity and network reorganization.
The time course pattern of the regulation of functional protein groups points to another interesting aspect. There is an ongoing discussion to what extent pathophysiological mechanisms during epileptogenesis overlap with those in the early phase following epilepsy manifestation and progression phases (Dudek and Staley, 2011) . Our findings indicate that some of the molecular pathological processes extend into the chronic phase with spontaneous recurrent seizures. However, the degree of their regulation is reduced to lower levels with a smaller number of proteins being regulated per functional group.
Systems biology approaches and network analyses of omics-data sets can render an important information basis for network pharmacology approaches with multi-targeting strategies or targeting of key transcription factors (Margineanu, 2016 , Benson, 2015 , Haanstra and Bakker, 2015 . Löscher et al. (2013) have emphasized that there is an urgent need in the epileptology field for a gain-in-knowledge rendering rational design of multi-targeting approaches and drug cocktails possible. In line with these concepts we now applied a WGCNA resulting in the identification of several modules of interconnected protein groups, which reflect distinct
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21 molecular aspects of epileptogenesis in the electrical post-SE model in rats. In order to assess the robustness of the findings we included another data set recently published by (Bitsika et al., 2016 ) from a chemical mouse post-SE model in a direct comparative analysis.
The functional association of significantly enriched pathways characterizing the identified modules points to key pathophysiological mechanisms. It is a well-known fact that epileptogenic brain insults trigger neuronal damage and loss (Pitkänen et al., 2002) . HC module 4 proved to be characterized by the regulation of molecular signaling pathways that are critically involved in the regulation of cell death and apoptosis. Whereas altered 14-3-3 signaling has previously been discussed in the context of temporal lobe epilepsy (Schindler et al., 2006) , there has been only limited or no information available about the role of Myc mediated apoptosis signaling, HIPPO signaling, and protein ubiquitination during epileptogenesis. HIPPO signaling is known to play a crucial role in the regulation of cell proliferation and apopotosis (Cairns et al., 2017) as well as in tumorigenesis (Zhang et al., 2016) . In addition, a link has been described between HIPPO signaling and 14-3-3 proteins (Ren et al., 2010) .
The involvement of further pathways was evident in PHC module 5. Among these, mTOR signaling was repeatedly described to be modulated during epileptogenesis and in the epileptic brain (Vezzani, 2012 , Galanopoulou et al., 2012 . In apparent contrast, there has been a lack of robust information about epileptogenesis-or epilepsy-associated regulation of signaling pathways linked with eukaryotic initiation factor and ribosomal protein S6 kinase beta-1 signaling. These pathways are associated with protein synthesis and macroauthophagy and a role of these pathways has been discussed in the context of Parkinson's disease (Dijkstra et al., 2015) . Respective pathways might comprise interesting target candidates for neuroprotective approaches.
Cellular plasticity constitutes one of the hallmarks of the development of temporal lobe epilepsy following an initial brain insult (Jessberger and Parent, 2015) . Two of the HC
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22 modules (module 3 and 6) and one of the PHC modules (module 8) stood out with a regulation of pathways linked with cytoskeletal dynamics, cell-cell interaction, and axonal guidance. The identification of these pathways provides important molecular information for future development of innovative approaches interfering with the generation of a hyperexcitable cellular network. In the PHC, proteins associated with leukocyte extravasation signaling exhibited an intense regulation. Recently, we have already discussed respective molecular alterations and their implications in detail (Walker et al., 2016) . In this previous publication, we have completed a bioinformatics analysis focused on inflammation and immunity-associated pathways. Despite the fact that some of the respective pathways were also key components of those network modules, which proved to be regulated following SE, the number of hub proteins and regulated module pathways linked with inflammation is relatively low. This might be related to a role of inflammation-associated proteins as crucial effector proteins rather than key regulatory proteins.
Moreover, assessment of regulated pathways characterizing HC module 6 pointed to a molecular overlap with pathophysiological mechanisms of other neurological diseases. The comparison of the neurobiology of Alzheimer's disease and epilepsy has already been a focus of experimental and clinical studies (Noebels, 2011, Chin and Scharfman, 2013) . In contrast, the mechanistic link between Huntington's disease and epilepsy suggested by our findings needs to be further explored.
In general, it is of interest that several hub proteins of different modules have already been linked with various neurological and psychiatric diseases ( Figure 5 ). Among these hub proteins annexin A2, clusterin, and integrin subunit beta 1 are standing out exhibiting a link with multiple diseases.
The regulation of HC module 8 pathways linked with carbohydrate and amino acid metabolism might reflect a general metabolic dysfunction. Reid et al. (2014) have previously discussed that the modulation of metabolic pathways can affect seizure susceptibility. Taking
23 this discussion into account, the comprehensive metabolic alterations evident from our data sets might actually contribute to epileptogenesis. In addition, PHC modules 3 and 7 comprised pathways related to mitochondrial function or to mitochondrial dysfunction. It is known that alterations in cell respiration and in the generation of reactive oxygen species can affect epileptogenesis (Rowley et al., 2015) . Thus, this finding is in line with the already discussed association between mitochondrial dysfunction and epilepsy (Folbergrova and Kunz, 2012) .
Protein interaction networks are characterized by a small number of highly connected protein nodes referred to as hub proteins (He and Zhang, 2006) . The majority of the significantly regulated top 5 hub proteins that we identified in our data set can be assigned to functional pathways discussed above. However, some hub proteins stand out from a functional point of view. These include synaptotagmin serving as a calcium sensor function thereby regulating neurotransmitter release (Jackman et al., 2016) ; H2A histone family member Y, a nuclear protein influencing nucleosome structure and regulating transcription (Hu et al., 2011) as well as different annexins playing a role in pro-inflammatory arachidonic acid signaling (Creutz et al., 2012) . Several of these proteins including eukaryotic translation initiation factor 3 subunit C, H2A histone family member Y, hypoxia up-regulated 1, and transaldolase 1 have to our knowledge not been discussed in the context of epileptogenesis before.
Some of the intramodular hub proteins were also identified by PCA, such as, for instance, annexin A3. Junker et al. (2007) discussed a role for annexin A3 in apoptotic and phagocytotic processes in the brain. Thus, the detected upregulation in the latency phase, which was confirmed by immunohistochemistry, might be related to insult-triggered cell death.
On the first glimpse, hub proteins might serve as interesting target candidates based on their key switch function in the disease-associated protein-protein network. However, it needs to be
considered that deletion of hub proteins has a higher probability to be lethal than deletion of a non-hub protein (He and Zhang, 2006) . Thus, pharmacological targeting of hub proteins has a high potential for severe adverse effects and tolerability issues. Nevertheless, knowledge about hub proteins, their interactions and associated loops provides valuable information allowing integration of network biology in the design of module-based targeting approaches (Hopkins, 2008 , Wang et al., 2012 . It is interesting to note that we observed an overlap in the network data despite these contrasting characteristics of the constructive and face validity of the models. This fact points to shared molecular pathophysiological mechanisms between the models, which might further confirm a comparable predictability regarding target and biomarker identification.
During the early post-insult phase and the latency phase PCA analysis of data from both brain regions revealed an obvious clustering also pointing to proteins that best distinguish between groups. The top protein lists contributing to dimension 1 might suggest biomarker candidates,
25 which can serve as early molecular predictors of epileptogenesis following a brain insult. As mentioned in the introduction respective biomarkers might render a basis for molecular imaging approaches suitable for the identification of subgroups of patients at risk to develop epilepsy and for efficacy testing when evaluating anti-epileptogenic approaches. Thereby,
proteins exhibiting a prominent upregulation should provide the most interesting candidates.
Proteins, which as CD151 molecule proved to be overexpressed two days following SE, might be the most promising biomarkers for early risk assessment. It would be of particular interest to further study the regulation of CD151 molecule in more detail considering that CD151 molecule serves as a target for valproate and lithium in bipolar disorders (Hua et al., 2001 ) and that it might contribute to the regulation of blood-brain barrier tightness (Zhang et al., 2011) . Proteins being up-regulated ten days following SE such as plexin B2 might provide a basis for follow-up and efficacy testing of intervention strategies. In contrast, proteins exhibiting a significant induction following onset of epilepsy might serve as a valuable basis for early diagnosis of epilepsy manifestation. Based on our analysis, molecular alterations in the PHC rather than those in the HC can provide a basis for respective epilepsy biomarkers.
As a major limitation of any molecular study with brain tissue sampling at early time points following an epileptogenic brain insult, we could only base our study design on the choice of a model in which animals reliably develop spontaneous seizures. It needs to be taken into account that invasive sampling does not allow to subsequently obtain information about the outcome regarding epilepsy development. The current study design of course does not allow to finally conclude whether a selected molecular alteration is associated with epileptogenesis or whether it merely reflects a consequence of the initial brain insult. Thus, it will be of utmost interest to assess whether biomarker candidates reliably predict epileptogenesis in a model with subgroups of animals with or without development of spontaneous recurrent seizures. This however, will only be feasible with a non-invasive assessment of the biomarker candidates e.g. by molecular imaging. The situation would of course be different with
peripheral biomarkers from plasma or peripheral tissue as well as with cerebrospinal fluid sampling. Assessment of proteome alterations in respective samples should be further addressed in future studies. However, it needs to be taken into account that a sufficient number of proteins is necessary for a network analysis, which we have completed in the present study. The low number of proteins in CSF samples would therefore hamper this specific type of bioinformatics analysis.
Considering the outcome of the bioinformatics analysis it needs to be taken into account that databases used are based on a mixture of in vivo and in vitro data. With the currently available tools it is not possible to avoid a putative bias related to the fact that data obtained from an animal model are analysed based on these databases.
Moreover, data sets require validation by a focused analysis of selected proteins.
Immunohistochemical analysis can thereby also provide additional information about the subregion specific and cellular distribution of differentially expressed proteins. In the present study, we confirmed an up-regulation of three selected proteins. These included annexin A3, which has already been discussed above, the chaperone protein clusterin, and eukaryotic translation initiation factor 3 subunit C. To our knowledge a regulation of the latter protein has not been discussed previously in the context of epileptogenesis. Eukaryotic translation initiation factor 3 subunit C, serves an essential function during the initiation of protein synthesis (Emmanuel et al., 2013) . Silencing of its function can inhibit cell proliferation and promote apoptosis (Hao et al., 2015) . It might be of interest to further study the role of this protein during epileptogenesis in more detail in future studies.
In conclusion, the first systems level analysis of proteome alterations during the course of epileptogenesis identified several modules of highly connected proteins in the HC and PHC.
Characterization of the modules did not only further validate the data, but also revealed
regulation of molecular processes not described previously in the context of epilepsy development. The data sets also provide valuable information about temporal patterns required for the development of preventive strategies.
In addition, PCA analysis suggests candidate biomarkers, which might inform the design of novel molecular imaging approaches aiming to predict epileptogenesis during different phases or to confirm epilepsy manifestation.
It is emphasized that the study design and the findings do not yet allow to distinguish between proteins that are undoubtedly linked with epileptogenesis and do not only reflect a molecular consequence of SE. Further studies with sequential molecular imaging in models with subgroups with and without epilepsy development, will be crucial to provide relevant information about selected candidates. Moreover, application of network analysis to other models of epileptogenesis with different types of epileptogenic insults including models of traumatic brain injury or ischemia will provide data for comparison allowing the identification of key epileptogenesis proteins. Tables   Table 1 Top 5 
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